Ok Biotech Co Ltd Market Cap ($60.97 Million)
Market Cap & Net Worth: Ok Biotech Co Ltd (4155)
Ok Biotech Co Ltd market cap. Ok Biotech Co Ltd (TW:4155) has a market capitalization of $60.97 Million (NT$1.94 Billion) as of November 4, 2026. Listed on the TW stock exchange, this Taiwan-based company holds position #20919 globally and #1267 in its home market, demonstrating a -0.89% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ok Biotech Co Ltd's stock price NT$16.65 by its total outstanding shares 116233998 (116.23 Million). Also see Ok Biotech Co Ltd (4155) cash flow conversion for how efficiently the company converts equity into cash flow.
Ok Biotech Co Ltd Market Cap History (2015–2026)
Ok Biotech Co Ltd market cap history from 2015 to 2026. Data shows growth from $75.27 Million to $60.97 Million (0.99% CAGR). Check Ok Biotech Co Ltd stock quote for real-time trading data and today's change.
Ok Biotech Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ok Biotech Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 4155 shareholders equity momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.03x
Ok Biotech Co Ltd's market cap is 0.03 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.64x
Ok Biotech Co Ltd's market cap is 0.64 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $66.88 Million | $1.04 Billion | $85.20 Million | 0.06x | 0.79x |
| 2017 | $73.03 Million | $1.23 Billion | $126.81 Million | 0.06x | 0.58x |
| 2018 | $62.82 Million | $1.12 Billion | $161.36 Million | 0.06x | 0.39x |
| 2019 | $91.35 Million | $1.24 Billion | $125.76 Million | 0.07x | 0.73x |
| 2020 | $77.00 Million | $1.48 Billion | $129.73 Million | 0.05x | 0.59x |
| 2021 | $70.39 Million | $1.26 Billion | $31.42 Million | 0.06x | 2.24x |
| 2022 | $86.70 Million | $1.48 Billion | $143.46 Million | 0.06x | 0.60x |
| 2023 | $90.78 Million | $1.19 Billion | $2.95 Million | 0.08x | 30.79x |
| 2024 | $74.89 Million | $1.67 Billion | $93.97 Million | 0.04x | 0.80x |
| 2025 | $53.10 Million | $1.56 Billion | $82.45 Million | 0.03x | 0.64x |
Competitor Companies of 4155 by Market Capitalization
Companies near Ok Biotech Co Ltd in the global market cap rankings as of November 4, 2026. Also see 4155 total asset value for a full breakdown of the balance sheet.
Key companies related to Ok Biotech Co Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #110 globally with a market cap of $190.23 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #204 globally with a market cap of $119.12 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #226 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #239 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #110 | Abbott Laboratories | NYSE:ABT | $190.23 Billion | $109.40 |
| #204 | Stryker Corporation | NYSE:SYK | $119.12 Billion | $310.55 |
| #226 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $98.88 |
| #239 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Ok Biotech Co Ltd (2015–2026)
Market capitalization of Ok Biotech Co Ltd from 2015 to today. Between 2015 and today, Ok Biotech Co Ltd's market cap moved from $75.27 Million to $ 60.97 Million, with a yearly change of 0.99%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$60.97 Million | +14.83% |
| 2025 | NT$53.10 Million | -29.10% |
| 2024 | NT$74.89 Million | -17.51% |
| 2023 | NT$90.78 Million | +4.70% |
| 2022 | NT$86.70 Million | +23.16% |
| 2021 | NT$70.39 Million | -8.58% |
| 2020 | NT$77.00 Million | -15.71% |
| 2019 | NT$91.35 Million | +45.41% |
| 2018 | NT$62.82 Million | -13.98% |
| 2017 | NT$73.03 Million | +9.19% |
| 2016 | NT$66.88 Million | -11.14% |
| 2015 | NT$75.27 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Ok Biotech Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $60.97 Million USD |
| MoneyControl | $60.97 Million USD |
| MarketWatch | $60.97 Million USD |
| marketcap.company | $60.97 Million USD |
| Reuters | $60.97 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Ok Biotech Co Ltd
OK Biotech Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of blood glucose monitoring systems and homecare healthcare devices in Taiwan, the rest of Asia, America, Africa, and Europe. The company offers nebulizers, blood glucose meters, glucometers, blood sugar meters, and blood glucose test strips. It also provides OTC hearing aids, multi-f… Read more